| scholarly article | Q13442814 |
| P356 | DOI | 10.1074/JBC.M111727200 |
| P698 | PubMed publication ID | 11809756 |
| P2093 | author name string | Renée C LeBoeuf | |
| Cynthia M Vick | |||
| Sandra A Schreyer | |||
| P2860 | cites work | Lymphotoxin beta, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface | Q24320309 |
| A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells | Q28119154 | ||
| Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance | Q28131660 | ||
| Ath-1, a gene determining atherosclerosis susceptibility and high density lipoprotein levels in mice | Q28505210 | ||
| Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin | Q28507630 | ||
| Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection | Q28509078 | ||
| RAG-1-deficient mice have no mature B and T lymphocytes | Q28592133 | ||
| Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes | Q28593744 | ||
| Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice | Q28593915 | ||
| The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor | Q28610826 | ||
| Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death | Q29620021 | ||
| Tumor necrosis factor receptor and Fas signaling mechanisms. | Q33652491 | ||
| Monocyte chemoattractant protein-1 but not tumor necrosis factor-alpha is correlated with monocyte infiltration in mouse lipid lesions | Q33860523 | ||
| Signaling through the lymphotoxin beta receptor induces the death of some adenocarcinoma tumor lines | Q34381306 | ||
| T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse | Q36142970 | ||
| A critical role for lymphotoxin in experimental allergic encephalomyelitis | Q36380767 | ||
| Quantitative assessment of atherosclerotic lesions in mice | Q36456167 | ||
| Increased atherosclerosis in streptozotocin-induced diabetic mice | Q37353969 | ||
| The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/- mice | Q37372718 | ||
| The Role of Tumor Necrosis Factor-α Receptors in Atherosclerosis | Q37828682 | ||
| The biology of cachectin/TNF--a primary mediator of the host response | Q38269386 | ||
| Tumor necrosis factor alpha (TNF-alpha)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55. | Q38319685 | ||
| Tumor necrosis factor's cytotoxic activity is signaled by the p55 TNF receptor | Q40853190 | ||
| Lymphotoxin-alpha is an autocrine growth factor for chronic lymphocytic leukemia B cells | Q41049086 | ||
| Induction of apoptosis in mature T cells by tumour necrosis factor | Q41293478 | ||
| Lymphotoxin alpha-/- mice develop functionally impaired CD8+ T cell responses and fail to contain virus infection of the central nervous system | Q45739093 | ||
| Detection and localization of tumor necrosis factor in human atheroma | Q46152807 | ||
| C57BL/6 mice fed high fat diets as models for diabetes-accelerated atherosclerosis. | Q51570758 | ||
| P433 | issue | 14 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | atherosclerosis | Q12252367 |
| P1104 | number of pages | 5 | |
| P304 | page(s) | 12364-12368 | |
| P577 | publication date | 2002-01-23 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Loss of lymphotoxin-alpha but not tumor necrosis factor-alpha reduces atherosclerosis in mice | |
| P478 | volume | 277 |
| Q46945717 | A functional polymorphism in the lymphotoxin-alpha gene is associated with carotid artery wall thickness: the Diabetes Heart Study |
| Q37365047 | A meta-analysis of candidate gene polymorphisms and ischemic stroke in 6 study populations: association of lymphotoxin-alpha in nonhypertensive patients |
| Q33947816 | Aging-related atherosclerosis is exacerbated by arterial expression of tumor necrosis factor receptor-1: evidence from mouse models and human association studies |
| Q46562417 | Association of the lymphotoxin-alpha gene Thr26Asn polymorphism with severity of coronary atherosclerosis. |
| Q26739070 | Cardiovascular risk assessment in patients with rheumatoid arthritis: The relevance of clinical, genetic and serological markers |
| Q49335652 | Correlations of chemokine CXCL16 and TNF-α with coronary atherosclerotic heart disease |
| Q44436182 | Cross-sectional study of risk factors for atherosclerosis in the Azorean population. |
| Q37071164 | Cyclooxygenase products and atherosclerosis |
| Q36802942 | Cytokines and atherosclerosis: a comprehensive review of studies in mice |
| Q31124912 | Data on gene and protein expression changes induced by apabetalone (RVX-208) in ex vivo treated human whole blood and primary hepatocytes |
| Q35900629 | Deficiency of lymphotoxin-α does not exacerbate high-fat diet-induced obesity but does enhance inflammation in mice |
| Q39645825 | Deletion of P2Y2 receptor reveals a role for lymphotoxin-α in fatty streak formation |
| Q34763602 | Deletion of the p66Shc longevity gene reduces systemic and tissue oxidative stress, vascular cell apoptosis, and early atherogenesis in mice fed a high-fat diet. |
| Q47140191 | Elucidation of Gene Expression Patterns in the Brain after Spinal Cord Injury. |
| Q46434986 | Free cholesterol-loaded macrophages are an abundant source of tumor necrosis factor-alpha and interleukin-6: model of NF-kappaB- and map kinase-dependent inflammation in advanced atherosclerosis |
| Q44212606 | Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction |
| Q33292125 | Functional variation in LGALS2 confers risk of myocardial infarction and regulates lymphotoxin-alpha secretion in vitro |
| Q64059939 | Galectins in the Pathogenesis of Cerebrovascular Accidents: An Overview |
| Q36165202 | Genetic markers of cardiovascular disease in rheumatoid arthritis. |
| Q36389322 | Genetic susceptibility to coronary artery disease: from promise to progress. |
| Q35223445 | Genetical genomics of Th1 and Th2 immune response in a baboon model of atherosclerosis risk factors |
| Q28066981 | Genetics of the acute coronary syndrome |
| Q34218772 | Genome-Wide Association Study of Coronary Artery Disease |
| Q37461235 | Increased ADAM17 mRNA expression and activity is associated with atherosclerosis resistance in LDL-receptor deficient mice |
| Q36504914 | Inflammation as a risk factor for myocardial infarction |
| Q39961306 | Inhibition of NF-kappaB activation in macrophages increases atherosclerosis in LDL receptor-deficient mice. |
| Q48766427 | Lymphotoxin-alpha gene 252G allelic variant is a risk factor for large-vessel-associated ischemic stroke |
| Q28199426 | Lymphotoxin-alpha gene and risk of myocardial infarction in 6,928 cases and 2,712 controls in the ISIS case-control study |
| Q36699758 | Lymphotoxin-α is a novel adiponectin expression suppressor following myocardial ischemia/reperfusion |
| Q34162072 | Modifications in lipid levels are independent of serum TNF-α in rheumatoid arthritis: results of an observational 24-week cohort study comparing patients receiving etanercept plus methotrexate or methotrexate as monotherapy |
| Q38125279 | Molecular biology of atherosclerosis |
| Q33869955 | Mouse aorta smooth muscle cells differentiate into lymphoid tissue organizer-like cells on combined tumor necrosis factor receptor-1/lymphotoxin beta-receptor NF-kappaB signaling |
| Q42008483 | P2Y2 receptor-mediated lymphotoxin-α secretion regulates intercellular cell adhesion molecule-1 expression in vascular smooth muscle cells |
| Q53487070 | Plasma cytokines, metabolic syndrome, and atherosclerosis in humans. |
| Q38293434 | Regulation of HDL genes: transcriptional, posttranscriptional, and posttranslational |
| Q35541858 | Role of Monocytes in Atherogenesis |
| Q46875220 | Surfactant protein D is proatherogenic in mice. |
| Q42100605 | TRAIL attenuates the development of atherosclerosis in apolipoprotein E deficient mice |
| Q46517820 | The effect of acute ophiobolin A treatment on HO-mediated inflammatory processes |
| Q28594304 | The protective effect of A20 on atherosclerosis in apolipoprotein E-deficient mice is associated with reduced expression of NF-kappaB target genes |
| Q35792034 | The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice |
| Q37770209 | The unexpected role of lymphotoxin beta receptor signaling in carcinogenesis: from lymphoid tissue formation to liver and prostate cancer development |
| Q35952305 | Thematic review series: the immune system and atherogenesis. Immune function in atherogenesis |
| Q54497929 | Tumor necrosis factor-alpha deficiency retards early fatty-streak lesion by influencing the expression of inflammatory factors in apoE-null mice. |
| Q28488447 | Tumor necrosis factor-α and lymphotoxin-α mediate myocardial ischemic injury via TNF receptor 1, but are cardioprotective when activating TNF receptor 2 |
Search more.